New version of the RayCare OIS released including the new feature package RayCare Flow

RaySearch has released RayCare® 3A*, a new version of the next generation oncology information system (OIS). RayCare is designed to support the workflow in a modern oncology center, connecting the different oncology disciplines, boosting efficiency and ensuring optimal use of resources. RayCare is rapidly developing in collaboration with some of the leading cancer centers worldwide.

RayCare is now in clinical use at three centers world-wide. The most recent addition is Heidelberg University Hospital in Germany, who started using RayCare clinically in May this year. The other two centers have been using RayCare since 2018, first at Iridium Cancer Network in Belgium, and at Provision CARES Proton Therapy Center in Nashville, USA. Today, RaySearch releases the first of this year`s two major versions, RayCare 3A.

RayCare 3A brings several new features to support the efficiency and workload control for users. The enhanced ‘Home’ workspace provides a comprehensive overview for each user’s activities, including new features such as task statistics to guide daily priorities and the option to pin tasks of interest. The RayCare workflow engine now supports modular patient workflows. This advanced feature enables the evolution of the patient workflow by adding modules of tasks when different clinical decision points are reached. The modularization of the digital workflows makes it possible to tailor the workflows to the specific patient needs and further streamline the flow of the clinic.

It also adds the patient chart summary feature that provides an at-a-glance patient-centered overview and a hub for quick navigation to important workspaces. It will also be possible to automatically trigger plan generation protocols in RayStation from RayCare, based on availability of image data. Furthermore, there are usability and performance enhancements throughout the product as well as extended connectivity with other hospital systems.  

RayCare 3A introduces RayCare Flow, a feature package designed to connect the RayStation treatment planning system with the powerful workflow management capabilities of RayCare and RayCare PACS. RayCare Flow optimizes the treatment planning process by providing automated task management for all the steps in the planning workflow. With this solution, RayCare becomes the environment from which treatment planning is coordinated and managed. To support resource management and workload visibility of planning tasks, RayCare Flow includes an interactive real-time planning whiteboard. RayCare Flow can improve resource management, increase efficiency of treatment planning workflow and capture all clinical communications, as well as automate image management.

Johan Löf, CEO of RaySearch, says: “I’m delighted to see another release of RayCare, an OIS that is built for the needs of modern oncology and that will redefine cancer care. Our decision to package RayCare Flow shows that RaySearch always listens to the needs in the industry. RayCare Flow is a natural step for our RayStation customers, and it is an ideal first step towards a full RayCare implementation.” 

About RaySearch

RaySearch is a medical technology company that develops innovative software solutions to improve cancer care. The company markets the RayStation* treatment planning system and RayCare*, the next-generation oncology information system, worldwide. Over 2,600 clinics in more than 65 countries use RaySearch’s software to improve life and outcomes for patients. The company was founded in 2000 and the share has been listed on Nasdaq Stockholm since 2003.

About RayCare

RayCare is designed to support the complex logistical challenges of modern oncology clinics. It represents the future of oncology information system technology, supporting the vision of one oncology workflow. Many cancer patients receive a combination of treatment types, and RayCare is designed to reflect that. It will efficiently coordinate activities in radiation therapy, chemotherapy and surgery and will offer advanced features for clinical resource optimization, workflow automation and adaptive radiation therapy. RayCare is being developed with tomorrow’s requirements for advanced analytics and decision support in mind.

About RayStation

RayStation is a flexible, innovative treatment planning system, chosen by many of the leading cancer centers worldwide. It combines unique features such as unmatched adaptive therapy capabilities, multi-criteria optimization, market-leading algorithms for IMRT and VMAT optimization with highly accurate dose engines for photon, electron, proton and carbon ion therapy. RayStation supports a wide range of treatment machines, providing one control center for all treatment planning needs and ensuring centers get greater value from existing equipment. RayStation also seamlessly integrates with RayCare, the next-generation oncology information system. By harmonizing the treatment planning, we enable better care for cancer patients worldwide.

More information about RaySearch is available at www.raysearchlabs.com 

* Subject to regulatory clearance in some markets.

For further information, please contact:

Johan Löf, Founder and CEO, RaySearch Laboratories AB (publ)

Telephone: +46 (0)8-510 530 00

johan.lof@raysearchlabs.com 

Peter Thysell, CFO, RaySearch Laboratories AB (publ)

Telephone: +46 (0)70 661 05 59

peter.thysell@raysearchlabs.com

About Us

RaySearch Laboratories AB (publ) has been pushing the limits of advanced cancer treatment since 2000. Using progressive algorithms, RaySearch develops world leading software used by thousands of the most cutting-edge cancer clinics in the world. The algorithms are based upon founder and CEO Johan Löf’s scientific knowledge, acquired during his PhD on radiation treatment of moving tumors at the Karolinska Institute. The treatment planning system RayStation and the OIS RayCare are the result of extensive development during years of research, and today used to improve chances of survival and quality of life for cancer patients. We fight for a world where cancer is conquered.

Subscribe

Media

Media

Documents & Links